UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 114

Sortiert nach

Phase II Study of Pembrolizumab in Combination with Doxorubicin in Metastatic and Unresectable Soft-Tissue Sarcoma

Clinical cancer research, 2021-12, Vol.27 (23), p.6424-6431

2021

Link zum Volltext

Verfügbarkeit prüfen

Assessing trends in breast care surveillance metrics after implementing surgeon-specific tracking and performance reporting in a large, integrated cancer network

Cancer, 2023-10, Vol.129 (20), p.3230-3238

2023

Link zum Volltext

Verfügbarkeit prüfen

Implementation of a Dedicated Enhanced Recovery after Surgery (ERAS) Program for Radical Cystectomy Patients is Associated With Decreased Postoperative Inpatient Opioid Usage and Pain Scores

Urology (Ridgewood, N.J.), 2020-09, Vol.143, p.186-193

2020

Link zum Volltext

Verfügbarkeit prüfen

Discordance of high PD-L1 expression in primary and metastatic urothelial carcinoma lesions

Urologic oncology, 2019-05, Vol.37 (5), p.299.e19-299.e25

2019

Link zum Volltext

Verfügbarkeit prüfen

It's complicated: The relationship of non-narcotic medications and postoperative opioid use in radical cystectomy patients

Urologic oncology, 2024-10, Vol.42 (10), p.332.e1-332.e9

2024

Link zum Volltext

Verfügbarkeit prüfen

Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma

British journal of haematology, 2019-07, Vol.186 (1), p.140-144

2019

Link zum Volltext

Verfügbarkeit prüfen

Necessity of Bony Fusion After Surgical Treatment of Metastatic Spine Tumors

Journal of the American Academy of Orthopaedic Surgeons, 2020-10, Vol.28 (19), p.e853

2020

Link zum Volltext

Verfügbarkeit prüfen

Ductal Carcinoma In Situ with Microinvasion on Core Biopsy: Evaluating Tumor Upstaging Rate, Lymph Node Metastasis Rate, and Associated Predictive Variables

Annals of surgical oncology, 2019-11, Vol.26 (12), p.3874-3882

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of dedicated renal enhanced recovery after surgery (RERAS) program on postoperative opioid consumption and evaluation of surgeon-specific compliance to the program

Urologic oncology, 2022-08, Vol.40 (8), p.383.e23-383.e29

2022

Link zum Volltext

Verfügbarkeit prüfen

Persistent opioid and benzodiazepine use after radical cystectomy in enhanced recovery after surgery (ERAS) patients

Urologic oncology, 2023-10, Vol.41 (10), p.432-432.e9

2023

Link zum Volltext

Verfügbarkeit prüfen

Application of ACOSOG Z1071: Effect of Results on Patient Care and Surgical Decision-Making

Clinical breast cancer, 2018-08, Vol.18 (4), p.270-275

2018

Link zum Volltext

Verfügbarkeit prüfen

Survival Outcomes and Factors Associated with Revision Surgery for Metastatic Disease of the Spine

Journal of oncology, 2018-01, Vol.2018, p.6140381-6

2018

Link zum Volltext

Verfügbarkeit prüfen

Usefulness of BMI and the novel concept of skin to fascia length (STFL) in predicting length of stay (LOS), readmission, and complications following radical cystectomy (RC)

Journal of the American College of Surgeons, 2015-10, Vol.221 (4), p.e40-e40

2015

Link zum Volltext

Verfügbarkeit prüfen

It matters: day of week (DOW) and type of surgical assistant (SAT) (second attending [SA] vs fourth year resident [R-4] vs advanced care provider [ACP]) predict outcomes following radical cystectomy

Journal of the American College of Surgeons, 2015-10, Vol.221 (4), p.e38-e39

2015

Link zum Volltext

Verfügbarkeit prüfen

Do early postoperative lactic acid (LA) levels predict adverse outcomes after cystectomy?

Journal of the American College of Surgeons, 2015-10, Vol.221 (4), p.e38-e38

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of Body Mass Index (BMI) on the Incidence of Bortezomib -Induced Peripheral Neuropathy (BIPN) in Patients with Newly Diagnosed Multiple Myeloma (MM)

Blood, 2018-11, Vol.132 (Supplement 1), p.2002-2002

2018

Link zum Volltext

Verfügbarkeit prüfen

Observed survival benefit with limited exposure of durvalumab in unresectable stage III non-small cell lung cancer at a large community-based institution

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e20539-e20539

2021

Link zum Volltext

Verfügbarkeit prüfen

Daratumumab, pomalidomide, and dexamethasone in relapsed refractory multiple myeloma (RRMM): A comparison with contemporary clinical trials

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e20011-e20011

2021

Link zum Volltext

Verfügbarkeit prüfen

Germline thrombophilia gene alterations and thrombosis rates among patients with advanced germ cell tumors treated with chemotherapy

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17023-e17023

2023

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism (VTE) incidence and risk factors in patients (pts) with non-small cell lung cancer (NSCLC) receiving front-line therapy

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19293-e19293

2020

Link zum Volltext

Verfügbarkeit prüfen

Outcomes for transplant-eligible, newly diagnosed Black patients (Pts) with multiple myeloma (MM): The Levine Cancer Institute (LCI) experience

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.8053-8053

2022

Link zum Volltext

Verfügbarkeit prüfen

Central Memory T-Cell Differentiation Correlates with Depth of Response in Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab in Combination with Carfilzomib, Lenalidomide and Dexamethasone (Elo-KRd)

Blood, 2021-11, Vol.138 (Supplement 1), p.1585-1585

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-14-03: A pilot study of paclitaxel plus pembrolizumab in patients with metastatic HER2-negative breast cancer (PePPy)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-14-03

2022

Link zum Volltext

Verfügbarkeit prüfen

Understanding primary care provider (PCP) experiences with survivorship care plans (SCPs) and informational needs when caring for cancer survivors

Journal of clinical oncology, 2017-02, Vol.35 (5_suppl), p.98-98

2017

Link zum Volltext

Verfügbarkeit prüfen

A pilot study evaluating the safety, tolerability, and efficacy of doxorubicin and pembrolizumab in patients with metastatic or unresectable soft tissue sarcoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.11519-11519

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(98)

Publikationsform

Sprache

Englisch
(114)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II Study of Pembrolizumab in Combination with Doxorubicin in Metastatic and Unresectable Soft-Tissue Sarcoma

Assessing trends in breast care surveillance metrics after implementing surgeon-specific tracking and performance reporting in a large, integrated cancer network

Implementation of a Dedicated Enhanced Recovery after Surgery (ERAS) Program for Radical Cystectomy Patients is Associated With Decreased Postoperative Inpatient Opioid Usage and Pain Scores

Discordance of high PD-L1 expression in primary and metastatic urothelial carcinoma lesions

It's complicated: The relationship of non-narcotic medications and postoperative opioid use in radical cystectomy patients

Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma

Necessity of Bony Fusion After Surgical Treatment of Metastatic Spine Tumors

Ductal Carcinoma In Situ with Microinvasion on Core Biopsy: Evaluating Tumor Upstaging Rate, Lymph Node Metastasis Rate, and Associated Predictive Variables

Impact of dedicated renal enhanced recovery after surgery (RERAS) program on postoperative opioid consumption and evaluation of surgeon-specific compliance to the program

Persistent opioid and benzodiazepine use after radical cystectomy in enhanced recovery after surgery (ERAS) patients

Application of ACOSOG Z1071: Effect of Results on Patient Care and Surgical Decision-Making

Survival Outcomes and Factors Associated with Revision Surgery for Metastatic Disease of the Spine

Usefulness of BMI and the novel concept of skin to fascia length (STFL) in predicting length of stay (LOS), readmission, and complications following radical cystectomy (RC)

It matters: day of week (DOW) and type of surgical assistant (SAT) (second attending [SA] vs fourth year resident [R-4] vs advanced care provider [ACP]) predict outcomes following radical cystectomy

Do early postoperative lactic acid (LA) levels predict adverse outcomes after cystectomy?

Impact of Body Mass Index (BMI) on the Incidence of Bortezomib -Induced Peripheral Neuropathy (BIPN) in Patients with Newly Diagnosed Multiple Myeloma (MM)

Observed survival benefit with limited exposure of durvalumab in unresectable stage III non-small cell lung cancer at a large community-based institution

Daratumumab, pomalidomide, and dexamethasone in relapsed refractory multiple myeloma (RRMM): A comparison with contemporary clinical trials

Germline thrombophilia gene alterations and thrombosis rates among patients with advanced germ cell tumors treated with chemotherapy

Venous thromboembolism (VTE) incidence and risk factors in patients (pts) with non-small cell lung cancer (NSCLC) receiving front-line therapy

Outcomes for transplant-eligible, newly diagnosed Black patients (Pts) with multiple myeloma (MM): The Levine Cancer Institute (LCI) experience

Central Memory T-Cell Differentiation Correlates with Depth of Response in Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab in Combination with Carfilzomib, Lenalidomide and Dexamethasone (Elo-KRd)

Abstract P2-14-03: A pilot study of paclitaxel plus pembrolizumab in patients with metastatic HER2-negative breast cancer (PePPy)

Understanding primary care provider (PCP) experiences with survivorship care plans (SCPs) and informational needs when caring for cancer survivors

A pilot study evaluating the safety, tolerability, and efficacy of doxorubicin and pembrolizumab in patients with metastatic or unresectable soft tissue sarcoma

Suchergebnisse filtern